1. Academic Validation
  2. Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation

  • Cell Rep. 2018 Aug 14;24(7):1722-1729. doi: 10.1016/j.celrep.2018.07.041.
Ryan Raisner 1 Samir Kharbanda 2 Lingyan Jin 1 Edwin Jeng 3 Emily Chan 4 Mark Merchant 4 Peter M Haverty 5 Russell Bainer 5 Tommy Cheung 6 David Arnott 6 E Megan Flynn 7 F Anthony Romero 8 Steven Magnuson 9 Karen E Gascoigne 10
Affiliations

Affiliations

  • 1 Department of Discovery Oncology, Genentech, Inc., South San Francisco, CA 94080, USA.
  • 2 Calico Labs, South San Francisco, CA 94080, USA.
  • 3 Program in Cancer Biology and Department of Genetics, Stanford University, Stanford, CA 94305, USA.
  • 4 Department of Translational Oncology, Genentech, Inc., South San Francisco, CA 94080, USA.
  • 5 Department of Bioinformatics, Genentech, Inc., South San Francisco, CA 94080, USA.
  • 6 Department of Protein Science, Genentech, Inc., South San Francisco, CA 94080, USA.
  • 7 Department of Early Discovery Biochemistry, Genentech, Inc., South San Francisco, CA 94080, USA.
  • 8 Unity Biotechnology, Brisbane, CA 94005, USA.
  • 9 Department of Discovery Chemistry, Genentech, Inc., South San Francisco, CA 94080, USA.
  • 10 Department of Discovery Oncology, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: [email protected].
Abstract

Acetylation of histone H3 at lysine 27 is a well-defined marker of enhancer activity. However, the functional impact of this modification at enhancers is poorly understood. Here, we use a chemical genetics approach to acutely block the function of the cAMP response element binding protein (CREB) binding protein (CBP)/P300 bromodomain in models of hematological malignancies and describe a consequent loss of H3K27Ac specifically from enhancers, despite the continued presence of CBP/P300 at chromatin. Using this approach to dissect the role of H3K27Ac at enhancers, we identify a critical role for this modification in the production of enhancer RNAs and transcription of enhancer-regulated gene networks.

Keywords

CBP; H3K27Ac; P300; bromodomain; enhancer; histone acetylation.

Figures